Published in Sarcoidosis Vasc Diffuse Lung Dis on September 01, 1999
Detection of myocardial damage in patients with sarcoidosis. Circulation (2009) 2.31
Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol (2002) 2.21
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
Childhood sarcoidosis: A rare but fascinating disorder. Pediatr Rheumatol Online J (2008) 1.63
Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation (2008) 1.48
Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol (2012) 1.27
Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol (2005) 1.14
Metalworking fluid with mycobacteria and endotoxin induces hypersensitivity pneumonitis in mice. Am J Respir Crit Care Med (2005) 1.09
M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am J Pathol (2011) 1.05
Overview of neurosarcoidosis: recent advances. J Neurol (2014) 1.02
Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review. Clin Med Res (2010) 1.00
Human chitotriosidase: a sensitive biomarker of sarcoidosis. J Clin Immunol (2012) 1.00
Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol (2007) 0.97
Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int (2013) 0.97
Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis. Lung (2003) 0.96
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis. J Immunol (2013) 0.95
Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des Devel Ther (2013) 0.94
Granuloma formation in pulmonary sarcoidosis. Front Immunol (2013) 0.93
Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.93
Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med (2010) 0.93
Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression. J Clin Immunol (2012) 0.91
Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol (2003) 0.90
Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients. Clin Exp Immunol (2006) 0.90
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? Clin Exp Immunol (2009) 0.89
Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis. PLoS One (2016) 0.89
Genetic interstitial lung disease. Clin Chest Med (2011) 0.89
Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol (2010) 0.88
Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.87
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes (2012) 0.87
Is there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise. BMC Pulm Med (2007) 0.87
Gene-environment interactions in sarcoidosis: challenge and opportunity. Clin Dermatol (2007) 0.86
Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study. Osteoporos Int (2008) 0.85
Ocular sarcoidosis in a Korean population. J Korean Med Sci (2009) 0.85
Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis. Lung (2015) 0.85
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med (2014) 0.85
Prognosis of refractory neurosarcoidosis altered by thalidomide: a case report. J Med Case Rep (2008) 0.85
Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis. World J Cardiol (2014) 0.85
Sarcoidosis incidentally diagnosed: a case report. Case Rep Pulmonol (2014) 0.84
[Pulmonary granulomatous diseases and pulmonary manifestations of systemic granulomatous disease : Including tuberculosis and nontuberculous mycobacteriosis]. Radiologe (2016) 0.84
Sarcoidosis: sex-dependent variations in presentation and management. J Ophthalmol (2014) 0.84
Subcutaneous sarcoidosis: a rare involvement of the paralateral nasal region. Acta Otorhinolaryngol Ital (2010) 0.84
Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med (2005) 0.84
A rare case of pulmonary tuberculosis with simultaneous pulmonary and skin sarcoidosis: a case report. Cases J (2010) 0.84
Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study. Fibrogenesis Tissue Repair (2010) 0.83
Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients. Respir Res (2013) 0.82
Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients. Lung (2007) 0.82
Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients? Lung (2012) 0.81
A sarcoidosis patient with hand involvement and large pulmonary lymph nodes: results of 1-year treatment with methotrexate. Clin Rheumatol (2010) 0.81
My approach to interstitial lung disease using clinical, radiological and histopathological patterns. J Clin Pathol (2009) 0.81
Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis. Fibrogenesis Tissue Repair (2011) 0.81
Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res (2001) 0.81
Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis. Arch Immunol Ther Exp (Warsz) (2014) 0.81
Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy. J Neurol (2010) 0.81
Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors. Lung (2012) 0.80
Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosis. Eur J Med Res (2009) 0.80
Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis. Eur J Immunol (2013) 0.80
Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis? Inflammation (2011) 0.80
Serum ACE Level in Sarcoidosis Patients with Typical and Atypical HRCT Manifestation. Pol J Radiol (2016) 0.79
Sarcoidosis in a 65-year-old woman presenting with a lung mass and pericardial effusion: a case report. J Med Case Rep (2012) 0.79
Diagnostic value of peripheral lymph node biopsy in sarcoidosis: a report of 67 cases. Can Respir J (2007) 0.79
A case series in patients with enteropathy and granulomatous diseases. BMC Gastroenterol (2015) 0.79
Laparoscopic splenectomy for isolated splenic sarcoidosis. JSLS (2014) 0.79
BTNL2 gene SNPs as a contributing factor to sarcoidosis pathogenesis in a cohort of Greek patients. Meta Gene (2014) 0.79
Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag (2016) 0.79
Early-onset childhood sarcoidosis with incidental multiple enchondromatosis. J Korean Med Sci (2011) 0.78
Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes. Eur J Med Res (2009) 0.78
Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis. J Transl Med (2012) 0.78
Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis. J Clin Immunol (2003) 0.78
Risk of Malignancy Among Patients With Sarcoidosis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken) (2016) 0.78
Pulmonary hypertension in parenchymal lung disease. Pulm Med (2012) 0.77
Cancer, infection and disturbances of the integrity of tissue homeostasis: the most significant triggers for molecular mimicry and autoimmunity in dermatology? Wien Med Wochenschr (2014) 0.77
Genetic profiles of Propionibacterium acnes and identification of a unique transposon with novel insertion sequences in sarcoid and non-sarcoid isolates. Sci Rep (2015) 0.77
CT-diagnosed emphysema and prognosis of chronic airflow obstruction: a retrospective study. BMJ Open (2013) 0.77
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir Med (2015) 0.77
A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis. BMC Pulm Med (2012) 0.77
Utility of endoscopic ultrasound-guided transbronchial fine-needle cytology in the diagnosis of sarcoidosis: A Saudi experience. Cytojournal (2014) 0.77
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage (2012) 0.77
Chitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPD. Allergy Asthma Immunol Res (2014) 0.77
Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis. Lung (2014) 0.76
Rare localizations of bone sarcoidosis: two case reports and review of the literature. Rheumatol Int (2009) 0.76
Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report. J Med Case Rep (2014) 0.76
Pulmonary hypertension caused by sarcoidosis. Clin Chest Med (2008) 0.76
Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach. Clin Pulm Med (2016) 0.76
The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases. BMC Ophthalmol (2016) 0.76
Gingival enlargement unveiling sarcoidosis: Report of a rare case. Contemp Clin Dent (2013) 0.76
Development of a T7 Phage Display Library to Detect Sarcoidosis and Tuberculosis by a Panel of Novel Antigens. EBioMedicine (2015) 0.76
Molecular Analysis of Sarcoidosis Granulomas Reveals Antimicrobial Targets. Am J Respir Cell Mol Biol (2016) 0.76
Sarcoidosis presenting as complete heart block in a 45-year-old farmer: an aetiology not to miss. J R Soc Med (2013) 0.75
A Case of Sarcoidosis with Unusual Radiographic Findings that Developed 5 Years after Silicone Augmentation Mammoplasty Complicated by Miliary Tuberculosis during Corticosteroid Treatment. Case Rep Pulmonol (2011) 0.75
Unilateral pulmonary hilar tumor mass: is it always lung cancer? Maedica (Buchar) (2013) 0.75
Bacterial antigens and molecular mimicry: the bridging common problematic link in the pathogenesis of sarcoidosis and sarcoid-like reactions: Isn't it time to wake up? Wien Med Wochenschr (2014) 0.75
Unexpected hypercalcemia in a diabetic patient with kidney disease. World J Nephrol (2015) 0.75
Sarcoidosis Presenting as Löfgren's Syndrome with Myopathy. Case Rep Rheumatol (2013) 0.75
Isolated facial cutaneous sarcoidosis. J Nat Sci Biol Med (2012) 0.75
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup. Case Reports Immunol (2014) 0.75
Sickle cell anemia patient with sarcoidosis-associated inguinal lymph node and lung infiltration. J Natl Med Assoc (2005) 0.75
Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis. Metabolomics (2016) 0.75
Rituximab in refractory sarcoidosis: a single centre experience. Clin Mol Allergy (2015) 0.75
Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities. BMC Musculoskelet Disord (2008) 0.75
STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. J Exp Med (1934) 14.72
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
Life course epidemiology. J Epidemiol Community Health (2003) 6.75
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA (1996) 5.95
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill (2012) 4.95
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet (1998) 4.05
Relation between income inequality and mortality: empirical demonstration. BMJ (1999) 3.98
Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol (2003) 3.93
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2001) 3.69
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest (1983) 3.41
Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res (2000) 3.32
Income inequality, social cohesion, and class relations: a critique of Wilkinson's neo-Durkheimian research program. Int J Health Serv (1999) 3.06
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie (2013) 3.03
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86
Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med (1998) 2.69
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain (1995) 2.69
Health inequalities and social inequalities in health. Bull World Health Organ (2000) 2.64
Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax (1993) 2.62
Total anomalous pulmonary venous connection: Report of 93 autopsied cases with emphasis on diagnostic and surgical considerations. Am Heart J (1976) 2.54
Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer (1995) 2.53
Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat (1988) 2.51
Course and prognosis of sarcoidosis around the world. Am J Med (1974) 2.41
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol (1999) 2.37
Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc Natl Acad Sci U S A (1987) 2.35
Five-year analysis of protective isolation. Lancet (1971) 2.31
Effect of phosphorus deficiency on growth angle of basal roots in Phaseolus vulgaris. New Phytol (1996) 2.28
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis (2008) 2.27
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J (1998) 2.23
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
Anatomically corrected malposition of the great arteries (S, D, L). Circulation (1975) 2.20
ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J (1999) 2.20
Laparoscopic cholecystectomy. A statewide experience. The Connecticut Laparoscopic Cholecystectomy Registry. Arch Surg (1993) 2.16
Tracheobronchopathia osteochondroplastica: a study of 41 patients. Medicine (Baltimore) (2001) 2.11
Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) (1999) 2.11
Two fatalities from ingestion of acetonitrile: limited specificity of analysis by headspace gas chromatography. J Anal Toxicol (1992) 2.09
Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet (2000) 2.08
Lymphatic manifestations of lymphangioleiomyomatosis. Lymphology (2014) 2.06
Traumatic subarachnoid-pleural fistula. Ann Thorac Surg (1996) 2.05
Social inequality in health, responsibility and egalitarian justice. J Public Health (Oxf) (2013) 2.02
Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology (1999) 1.99
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J (2008) 1.99
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J (2003) 1.97
Women's exposure to early and later life socioeconomic disadvantage and coronary heart disease risk: the Stockholm Female Coronary Risk Study. Int J Epidemiol (2001) 1.94
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 1.93
Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol (1997) 1.92
Antioxidant activity of curcumin and related compounds. Biochem Pharmacol (1976) 1.92
Relationship between premature mortality and socioeconomic factors in black and white populations of US metropolitan areas. Public Health Rep (2002) 1.91
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J (2004) 1.91
Benzene in the workplace. Am Ind Hyg Assoc J (1980) 1.88
Bone sarcoidosis. Curr Opin Rheumatol (2000) 1.83
Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France. Eur Respir J (1996) 1.83
Education and the metabolic syndrome in women. Diabetes Care (1999) 1.83
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer (2002) 1.79
Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest (1990) 1.79
Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res (2001) 1.78
T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet (1987) 1.77
Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid. Eur Respir J (1993) 1.77
Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999) 1.76
Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum (1999) 1.76
Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med (1989) 1.75
Primary cardiac sarcomas: an immunohistochemical and grading study with long-term follow-up of 24 cases. Histopathology (1999) 1.75
Synthesis of a muscarinic receptor antagonist via a diastereoselective Michael reaction, selective deoxyfluorination and aromatic metal-halogen exchange reaction. J Org Chem (2001) 1.75
Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol (2000) 1.74
Influx of na, k, and ca into roots of salt-stressed cotton seedlings : effects of supplemental ca. Plant Physiol (1987) 1.72
Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ (1995) 1.70
Treatment of sarcoidosis. Report of a controlled therapeutic trial. Lancet (1967) 1.69
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.67
A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet (1993) 1.66
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J (2008) 1.65
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med (1999) 1.65
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J (1999) 1.65
Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2000) 1.64
Sarcoidosis: unusual pulmonary manifestations. Postgrad Med (1977) 1.63
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Sarcoidosis presenting as bilateral hydronephrosis. Intern Med (1996) 1.63
Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem (1986) 1.62
Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients. Eur Respir J (2005) 1.62
Magnetic resonance cholangiopancreatography in obstructive jaundice. J Clin Gastroenterol (2004) 1.61
N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro. Sarcoidosis Vasc Diffuse Lung Dis (2009) 1.60
A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg (1984) 1.60
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol (1987) 1.59
Satisfaction of patients treated surgically for intractable aspiration. Chest (1999) 1.58
Microbial degradation of tannins--a current perspective. Biodegradation (1998) 1.58
Interruption of the aortic arch associated with deletion of chromosome 22q11 is associated with a subarterial and doubly committed ventricular septal defect in Japanese patients. Cardiol Young (1999) 1.58
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
[Opportunistic infections and sarcoidosis]. Rev Mal Respir (2004) 1.58